On January 14, 2016, Primed Biotech, together with Medical Research Council Technology (MRCT) and Chengdu Hi-tech Investment Group Co., Ltd. held the“New Drug Innovation & Collaboration Forum” in Tianfu Life & Science Park, Chengdu.

Over 40 senior executives of pharmaceutical companies, experts in biomedicine and scholars at home and abroad attended this forum themed “Innovation and Collaboration”.

Dr.Wen Zeng, Dr. Paul B Higgins of Primed and Dr. Zhi Zhang (Business DevelopmentManager, Asia/Pacific), Dr. David Matthews (Director of BioTherapeutics) and Dr. Debbie Taylor (Director of Bio-efficacy Evaluation) from Medical Research Council Technology (MRCT) addressed the meeting on the topics related to international co-creation of innovative drugs, therapeutic antibodies, small molecule drug discovery and non-alcoholic fatty liver disease (NAFLD). Thisforum has received extensive praise among attendees.